Invesaro

Stocks Health care LH

NYSE · Health care

Labcorp Holdings Inc. (LH)

Labcorp Holdings Inc. brought in $14.3B of revenue over the twelve months to June 30, 2026, up 6.4% from a year earlier. Net income was $1B, a net margin of 7.0%. Operating cash flow minus capital spending left $1.2B of free cash flow in fiscal 2025. At June 30, 2026 it held $141.8M in cash against $5.9B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.

Price
$309.64
+0.22% on the day · September 25, 2026
52-week range $244.52 to $341.80
Market cap
$25.1B
Revenue (last 12 months)
$14.3B
+6.4% year on year
Net margin
7.0%
P/E
29.6
on FY2025 diluted EPS

What Labcorp Holdings Inc. does

Labcorp Holdings Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NYSE under the ticker LH.

Revenue and profit by year

Revenue
FY18: $11.3B $11.3B FY18FY19: $11.6B $11.6B FY19FY20: $14B $14B FY20FY21: $13.1B $13.1B FY21FY21: $11.9B $11.9B FY21FY23: $12.2B $12.2B FY23FY24: $13B $13B FY24FY25: $14B $14B FY25
Net income
FY18: $883.7M $883.7M FY18FY19: $823.8M $823.8M FY19FY20: $1.6B $1.6B FY20FY21: $2.4B $2.4B FY21FY21: $1.3B $1.3B FY21FY23: $418M $418M FY23FY24: $746M $746M FY24FY25: $876.5M $876.5M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$14B$1.4B$876.5M$10.46$1.2B
2024$13B$1.1B$746M$8.84$1.1B
2023$12.2B$725.6M$418M$4.77$874.1M
2021$11.9B$1.4B$1.3B$13.97$1.5B
2021$13.1B$3B$2.4B$24.39$2.7B
2020$14B$2.4B$1.6B$15.88$1.8B

Latest SEC filings

What Labcorp Holdings Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 22, 2026
  2. September 10, 2026
  3. August 28, 2026
  4. August 17, 2026
  5. August 14, 2026
  6. August 5, 2026
    Quarterly report 10-Q · period to June 30, 2026
  7. July 30, 2026
  8. July 10, 2026
  9. June 30, 2026
  10. May 27, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 3, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about LH

What does Labcorp Holdings Inc. do?

Labcorp Holdings Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NYSE under the ticker LH.

Is Labcorp Holdings Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $1B on revenue of $14.3B, a net margin of 7.0%.

How much revenue does Labcorp Holdings Inc. make?

Over the twelve months to June 30, 2026 Labcorp Holdings Inc. reported revenue of $14.3B. That is 6.4% more than a year earlier.

When did Labcorp Holdings Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 22, 2026.

Similar companies

Follow LH

Get an email when Labcorp Holdings Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow LH: get an email when it files

Where the numbers come from

Financial figures are the values Labcorp Holdings Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.